![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: GTF3C2 |
Gene summary for GTF3C2 |
![]() |
Gene information | Species | Human | Gene symbol | GTF3C2 | Gene ID | 2976 |
Gene name | general transcription factor IIIC subunit 2 | |
Gene Alias | TF3C-beta | |
Cytomap | 2p23.3 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q8WUA4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
2976 | GTF3C2 | LZE4T | Human | Esophagus | ESCC | 7.45e-05 | 1.48e-01 | 0.0811 |
2976 | GTF3C2 | LZE7T | Human | Esophagus | ESCC | 1.24e-05 | 3.32e-01 | 0.0667 |
2976 | GTF3C2 | LZE8T | Human | Esophagus | ESCC | 1.26e-03 | 3.08e-02 | 0.067 |
2976 | GTF3C2 | LZE20T | Human | Esophagus | ESCC | 3.80e-05 | 5.08e-02 | 0.0662 |
2976 | GTF3C2 | LZE24T | Human | Esophagus | ESCC | 6.98e-07 | 2.29e-01 | 0.0596 |
2976 | GTF3C2 | LZE21T | Human | Esophagus | ESCC | 1.93e-04 | 2.30e-01 | 0.0655 |
2976 | GTF3C2 | LZE6T | Human | Esophagus | ESCC | 3.72e-03 | 1.97e-01 | 0.0845 |
2976 | GTF3C2 | P1T-E | Human | Esophagus | ESCC | 3.57e-05 | 3.34e-01 | 0.0875 |
2976 | GTF3C2 | P2T-E | Human | Esophagus | ESCC | 3.08e-31 | 5.13e-01 | 0.1177 |
2976 | GTF3C2 | P4T-E | Human | Esophagus | ESCC | 1.20e-05 | 1.78e-01 | 0.1323 |
2976 | GTF3C2 | P5T-E | Human | Esophagus | ESCC | 4.01e-14 | 1.92e-01 | 0.1327 |
2976 | GTF3C2 | P8T-E | Human | Esophagus | ESCC | 4.12e-17 | 2.80e-01 | 0.0889 |
2976 | GTF3C2 | P9T-E | Human | Esophagus | ESCC | 4.36e-07 | 1.14e-01 | 0.1131 |
2976 | GTF3C2 | P10T-E | Human | Esophagus | ESCC | 1.04e-28 | 4.21e-01 | 0.116 |
2976 | GTF3C2 | P11T-E | Human | Esophagus | ESCC | 2.63e-08 | 3.77e-01 | 0.1426 |
2976 | GTF3C2 | P12T-E | Human | Esophagus | ESCC | 8.97e-28 | 3.12e-01 | 0.1122 |
2976 | GTF3C2 | P15T-E | Human | Esophagus | ESCC | 3.33e-28 | 5.76e-01 | 0.1149 |
2976 | GTF3C2 | P16T-E | Human | Esophagus | ESCC | 9.86e-21 | 2.44e-01 | 0.1153 |
2976 | GTF3C2 | P17T-E | Human | Esophagus | ESCC | 1.92e-05 | 2.01e-01 | 0.1278 |
2976 | GTF3C2 | P19T-E | Human | Esophagus | ESCC | 5.91e-04 | 2.92e-01 | 0.1662 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00063833 | Esophagus | ESCC | transcription by RNA polymerase III | 41/8552 | 46/18723 | 7.69e-10 | 1.90e-08 | 41 |
GO:00987812 | Esophagus | ESCC | ncRNA transcription | 45/8552 | 56/18723 | 1.05e-07 | 1.72e-06 | 45 |
GO:00093032 | Esophagus | ESCC | rRNA transcription | 28/8552 | 34/18723 | 1.21e-05 | 1.12e-04 | 28 |
GO:0009303 | Liver | HCC | rRNA transcription | 25/7958 | 34/18723 | 2.42e-04 | 1.81e-03 | 25 |
GO:0006383 | Liver | HCC | transcription by RNA polymerase III | 31/7958 | 46/18723 | 5.67e-04 | 3.61e-03 | 31 |
GO:0098781 | Liver | HCC | ncRNA transcription | 33/7958 | 56/18723 | 9.64e-03 | 3.63e-02 | 33 |
GO:00063832 | Oral cavity | OSCC | transcription by RNA polymerase III | 34/7305 | 46/18723 | 1.61e-06 | 2.11e-05 | 34 |
GO:00987811 | Oral cavity | OSCC | ncRNA transcription | 38/7305 | 56/18723 | 1.15e-05 | 1.18e-04 | 38 |
GO:00093031 | Oral cavity | OSCC | rRNA transcription | 24/7305 | 34/18723 | 1.89e-04 | 1.28e-03 | 24 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 2 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
GTF3C2 | SNV | Missense_Mutation | rs754184411 | c.2432G>A | p.Arg811His | p.R811H | Q8WUA4 | protein_coding | tolerated(0.24) | benign(0) | TCGA-AX-A2HA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
GTF3C2 | SNV | Missense_Mutation | novel | c.1634C>A | p.Ser545Tyr | p.S545Y | Q8WUA4 | protein_coding | deleterious(0) | probably_damaging(0.986) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
GTF3C2 | SNV | Missense_Mutation | novel | c.1844N>A | p.Ala615Asp | p.A615D | Q8WUA4 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
GTF3C2 | SNV | Missense_Mutation | novel | c.1315N>A | p.Leu439Ile | p.L439I | Q8WUA4 | protein_coding | tolerated(0.09) | possibly_damaging(0.53) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
GTF3C2 | SNV | Missense_Mutation | c.722N>A | p.Gly241Asp | p.G241D | Q8WUA4 | protein_coding | tolerated(1) | benign(0) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
GTF3C2 | SNV | Missense_Mutation | novel | c.2534N>G | p.Asn845Ser | p.N845S | Q8WUA4 | protein_coding | deleterious(0) | probably_damaging(0.985) | TCGA-B5-A1MW-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
GTF3C2 | SNV | Missense_Mutation | novel | c.2648C>T | p.Ala883Val | p.A883V | Q8WUA4 | protein_coding | deleterious(0.03) | benign(0.162) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
GTF3C2 | SNV | Missense_Mutation | novel | c.1883N>C | p.Phe628Ser | p.F628S | Q8WUA4 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
GTF3C2 | SNV | Missense_Mutation | novel | c.348N>T | p.Gln116His | p.Q116H | Q8WUA4 | protein_coding | tolerated(0.09) | possibly_damaging(0.514) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
GTF3C2 | SNV | Missense_Mutation | novel | c.265N>C | p.Ser89Pro | p.S89P | Q8WUA4 | protein_coding | tolerated_low_confidence(0.38) | benign(0) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |